Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,527,000 shares of MIRM stock, worth $132 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
2,527,000
Previous 2,606,938
3.07%
Holding current value
$132 Million
Previous $108 Million
5.61%
% of portfolio
2.42%
Previous 2.07%
Shares
12 transactions
Others Institutions Holding MIRM
# of Institutions
228Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$355 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$249 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$146 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$133 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...